The Product Surveillance Registry REVERSE Post Approval Study

Inclusion Criteria

• •Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
• •Patient has or is intended to receive or be treated with a Medtronic CRT-D who meets the expanded CRT-D indication criteria with a QRS ≤ 150ms
• •Patient within 30 days of implant